news_6

Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data for Patritumab Deruxtecan in Patients with EGFR-Mutated NSCLC at ESMO 2020

HER3 directed ADC demonstrates clinical activity in patients with EGFR-mutated metastatic or unresectable NSCLC previously treated with a tyrosine kinase...

news_6

CyberLink Releases New Versions of its Director Family of Multimedia Editing Software, adding Spectacular effects, Precision Features and Expansive Stock Library

New AI-powered tools and comprehensive Shutterstock library featuring professional-grade photos, videos and audio empower creators of all skill levels to...